Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)


Legacy Pharmaceutical Packaging, LLC is recalling 3 repackaged lots of Losartan Tablets USP 50mg to the consumer level. This recall was prompted due to Torrent Pharmaceuticals LTD issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, (API manufacturer). (US Food Recalls) More More

Similar stories

Grant Park Packing Recalls Raw Ground Beef Products Due to Possible E. coli O103 Contamination - Food Poisoning News

Grant Park Packing Recalls Raw Ground Beef Products Due to Possible E. coli O103 Contamination  Food Poisoning News

Grant Park Packing, a Franklin Park, Sick. institution, is recalling roughly 53,200 kilos of uncooked floor beef merchandise which may be contaminated with E.

Posted on 25 April 2019 | 2:00 am | Google News

Recall expanded again for blood pressure medication linked to cancer risks - WJW FOX 8 News Cleveland

Recall expanded again for blood pressure medication linked to cancer risks  WJW FOX 8 News Cleveland

The FDA has announced that a recall for medication used to treat high blood pressure has been expanded again. According to the recall issued Wednesday, ...

Posted on 25 April 2019 | 2:00 am | Google News

Recon: Lilly to Withdraw Lartruvo; Gilead NASH Drug Fails in Second Phase III Study - Regulatory Focus

Recon: Lilly to Withdraw Lartruvo; Gilead NASH Drug Fails in Second Phase III Study  Regulatory Focus

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. Eli Lilly to Pull Cancer Drug From Market After ...

Posted on 25 April 2019 | 2:00 am | Google News

Jurox Incorporated is Voluntarily Recalling Two Lots of Alfaxan Unpreserved, an Intravenous Injectable Anaesthetic - Food Poisoning News

Jurox Incorporated is Voluntarily Recalling Two Lots of Alfaxan Unpreserved, an Intravenous Injectable Anaesthetic  Food Poisoning News

This recall has been initiated resulting from an out of specification outcome for readability noticed within the stability program. The presence of the aluminum ...

Posted on 24 April 2019 | 2:00 am | Google News

Recalls That Should Be on Your Radar-Week of April 21, 2019 - Contagionlive.com

Recalls That Should Be on Your Radar-Week of April 21, 2019  Contagionlive.com

We've compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week: Alvogen ...

Posted on 21 April 2019 | 2:00 am | Google News

Recalls That Should Be on Your Radar-Week of March 24, 2019 - Contagionlive.com

Recalls That Should Be on Your Radar-Week of March 24, 2019  Contagionlive.com

We've compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Posted on 30 March 2019 | 2:00 am | Google News

Copyright © 2019 LastMinuteStuff.com
Contact info